Shares of Reckitt Benckiser Group PLC (OTCMKTS:RBGLY – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the eight research firms that are covering the company, MarketBeat.com reports. Three analysts have rated the stock with a hold rating, three have given a buy rating and two have assigned a strong buy rating to the company.
A number of analysts have recently commented on the company. Deutsche Bank Aktiengesellschaft restated a “hold” rating on shares of Reckitt Benckiser Group in a research note on Tuesday, June 30th. Jefferies Financial Group raised Reckitt Benckiser Group from a “hold” rating to a “buy” rating in a report on Tuesday, July 21st. Zacks Research raised shares of Reckitt Benckiser Group from a “strong sell” rating to a “hold” rating in a research note on Monday, June 15th. Finally, Kepler Capital Markets raised shares of Reckitt Benckiser Group from a “hold” rating to a “strong-buy” rating in a report on Friday, April 17th.
View Our Latest Stock Report on RBGLY
Reckitt Benckiser Group Price Performance
Reckitt Benckiser Group Company Profile
Reckitt Benckiser Group plc is a multinational consumer goods company that develops, manufactures and markets health, hygiene and home products. Its portfolio spans over-the-counter medicines and health products, personal and sexual wellness, surface and laundry cleaning, and household care. The company owns a number of well-known global brands across these categories, including Lysol and Dettol in disinfectants and hygiene, Durex in sexual wellness, Nurofen in analgesics, and Finish in dishwashing products.
The firm has its corporate headquarters in the United Kingdom and sells products in markets around the world, serving consumers across North America, Europe, Asia, Latin America, the Middle East and Africa.
Further Reading
- Five stocks we like better than Reckitt Benckiser Group
- Chevron’s Strong Quarter Shows Why It Still Leads the Energy Sector
- Amazon’s Earnings Beat Shows Why AWS Is Back at the Center of the Bull Case
- Apple’s Record Quarter Could Not Outrun Its Guidance Problem
- McKesson’s Compounding Keeps Adding Up
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.
